DISCO Pharmaceuticals raises €20.0M Seed round

The funding will be used to unlock the surfaceome of cancer cells at scale, identify new targets, and develop first-in-class drugs, with initial pipeline programs in Small Cell Lung Cancer and Microsatellite-Stable Colorectal Cancer.

Source: https://www.prnewswire.com/news-releases/disco-pharmaceuticals-launches-as-the-surfaceome-company-with-eur-20-million-in-seed-financing-302035345.html